Bright Minds Biosciences (Bright Minds Biosciences) Total Assets : $5.13 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Bright Minds Biosciences Total Assets?

Bright Minds Biosciences's Total Assets for the quarter that ended in Dec. 2023 was $5.13 Mil.

During the past 12 months, Bright Minds Biosciences's average Total Assets Growth Rate was -63.00% per year. During the past 3 years, the average Total Assets Growth Rate was 17.90% per year.

During the past 4 years, Bright Minds Biosciences's highest 3-Year average Total Assets Growth Rate was 17.90%. The lowest was 17.90%. And the median was 17.90%.

Total Assets is connected with ROA %. Bright Minds Biosciences's annualized ROA % for the quarter that ended in Dec. 2023 was -98.27%. Total Assets is also linked to Revenue through Asset Turnover. Bright Minds Biosciences's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

Bright Minds Biosciences Total Assets Historical Data

The historical data trend for Bright Minds Biosciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bright Minds Biosciences Total Assets Chart

Bright Minds Biosciences Annual Data

Trend

Sep20

Sep21

Sep22

Sep23

Total Assets

0.67

15.82

9.06

5.08

Bright Minds Biosciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial												8.50	7.30	6.37	5.08	5.13

Bright Minds Biosciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Bright Minds Biosciences's Total Assets for the fiscal year that ended in Sep. 2023 is calculated as

Total Assets	=	Total Equity (A: Sep. 2023 )	+	Total Liabilities (A: Sep. 2023 )
	=	4.876	+	0.208
	=	5.08

Bright Minds Biosciences's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	4.497	+	0.637
	=	5.13

Bright Minds Biosciences (NAS:DRUG) Total Assets Explanation

Total Assets is connected with ROA %.

Bright Minds Biosciences's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-5.02	/	( (5.084	+	5.133)	/ 2 )
	=	-5.02	/	5.1085
	=	-98.27 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Bright Minds Biosciences's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0	/	( (5.084	+	5.133)	/ 2 )
=	0	/	5.1085
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Bright Minds Biosciences Total Assets Related Terms

Thank you for viewing the detailed overview of Bright Minds Biosciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Bright Minds Biosciences (Bright Minds Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bright Minds Biosciences Inc (NAS:DRUG) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

DRUG:Canada

Address

19 Vestry Street, New York, NY, USA, 10013

Website

https://www.brightmindsbio.com

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.